Belarus
This work includes introducing next-generation sequencing and phenotypic testing in laboratories, ensuring the sustainable supply of drugs for drug-resistant tuberculosis, providing training, and strengthening disease surveillance techniques.
The implementation and monitoring of an innovative, six-month, all-oral regimen for the treatment of drug-resistant TB continued within the framework of the operational study led by the Republican Scientific and Practical Center of Pulmonology and Phthisiology (RSPC PP) in the capital, Minsk. Patients from across the country were enrolled in the study and began treatment during the year.
Our activities in Belarus in 2024
Data and information from the International Activity Report 2024.
To ensure uninterrupted access to this treatment for all patients, we supplied the national TB programme with drugs, and our specialist advisors provided technical support to the staff responsible for reporting adverse effects and analysing medical data.
We also helped the RSPC PP laboratory prepare for the introduction of next-generation sequencing, a technology that enables faster detection of drug resistance, by organising a site visit to a laboratory jointly run by MSF and the Ministry of Health in Uzbekistan, which already uses the technology.
IN 2024
310
31
- Try a different country, year, format, or topic.
- Clear one or more filters